
Of all zzso zzso 50% currently occur in individuals zzso 65 years of age and this figure is expected to rise to zzso by zzso due to a progressive expansion of the older population zzso Clinical trials are needed in order to establish the benefits and risks of zzso treatment in older zzso It is reasonable to expect that the costs of these trials may be higher than in younger individuals, as older patients are more vulnerable to therapeutic complications and may need more supportive care, and the benefits of treatment may be less because of a reduced life-expectancy and competitive causes of death zzso This article explores a cost-effective approach to clinical trials in older individuals, after reviewing the basic concepts of economic analysis and unique aspects of geriatric zzso that may affect the cost of zzso In the process, the cost differences of cancer treatment in younger and older patients will be zzso 

